| Pre-randomization (day -7 to day 0): Check inclusion and exclusion criteria | |||||
---|---|---|---|---|---|---|
Zelen's randomization | ||||||
Parenteral nutrition group | Oral feeding group | |||||
Present "parenteral nutrition" info | Present "oral feeding" info | |||||
Day 1 | Days 2-60* | Day 61-death** | Day 1 | Days 2-60* | Day 61-death** | |
Obtain informed consent | X | Â | Â | X | Â | Â |
Record demographic data | X | Â | Â | X | Â | Â |
Take medical history | X | Â | Â | X | Â | Â |
Treatment | Â | Â | Â | Â | Â | Â |
Concomitant treatments | X | X | Â | X | X | Â |
Specific treatment (prior or ongoing) | X | X | Â | X | X | Â |
Patient status | Â | Â | Â | Â | Â | Â |
WHO Status | X | X | X | X | X | X |
Karnofsky index | X | X | Â | X | X | Â |
Estimated life expectancy | X | Â | Â | X | Â | Â |
Anthropometric data | Â | Â | Â | Â | Â | Â |
Height | X | Â | Â | X | Â | Â |
Weight | X | X | X | X | X | X |
Biology | Â | Â | Â | Â | Â | Â |
Lactic acid dehydrogenase | X | Â | Â | X | Â | Â |
C-reactive protein, albumin, prealbumin | X | X | Â | X | X | Â |
Blood count, electrolytes (including phosphorus, calcium, magnesium) | X | X | Â | Â | Â | Â |
Hepatic enzymes (AST, ALT, PAL, Gamma GT, Bilirubin) | X | X | Â | Â | Â | Â |
Triglycerides | X | X | Â | Â | Â | Â |
Ketonuria, glycosuria | X | X | Â | Â | Â | Â |
Quality of life questionnaires (QLQ-C15-PAL and QUAL-E***) | X | X | X | X | X | X |
Socio-economic variables | X | Â | Â | X | Â | Â |
Dietetics consultation | X | Â | Â | X | Â | Â |
Ingesta questionnaire | Â | X | X | Â | X | X |
Evaluation of metastatic disease | Â | X | Â | Â | X | Â |
Intervention supportive care | Â | X | Â | Â | X | Â |